IL2 and pancreatic neoplasm: In summary we tested various immunocytokines in pancreatic tumor models, finding that, unlike standard chemotherapy, L19-IL2, L19mIL12, and mIL2-F8-mTNF(mut) effectively eliminated tumors and extended survival, while L19mTNF and standard therapy did not improve outcomes.